Tiffany represents innovator life science and pharmaceutical companies in commercial, intellectual property, and antitrust disputes, handling all aspects of litigation from case inception through trial. Her litigation experience spans a broad range of subject matters that are critical to life science and pharmaceutical companies, from regulatory inspections to market access to supply agreements.
Tiffany also works with clients on transactional and FDA regulatory matters, including R&D collaboration agreements, patent licensing, and Orange Book listings. On the IP side, she has counseled clients and played an active role in inter partes review proceedings, intellectual property due diligences in connection with M&As, and validity and freedom-to-operate opinion work.
Over the years, Tiffany has actively volunteered within the firm as well as in various professional associations. She is currently a member of the firm’s Diversity Committee (2022) and previously served on its Pro Bono Committee (2020-22). She is also currently part of the leadership of Boston Patent Law Association, serving as Co-Chair of its Antitrust Committee.